PW

Peter Wung

Rheumatology

Credentials: · · ·

History

Rheumatology
2006–2008
Internal Medicine
2003–2006
Ohio State University College of Medicine
1999–2003

Research

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet · 2022 · 123 citations
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
Annals of the Rheumatic Diseases · 2022 · 115 citations
A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis
Annals of the Rheumatic Diseases · 2020 · 85 citations

AD
Atul Deodhar
7 papers
Anna Shmagel
3 papers
JS
John Stone
3 papers
Peter Merkel
3 papers
AS
Arathi Setty
2 papers
Eugene Clair
2 papers
Fredrick Wigley
2 papers
GH
Gary Hoffman
2 papers
John Davis
2 papers
Robert Spiera
2 papers
Ulrich Specks
2 papers
William McCune
2 papers